Duterte, The Philippines President apologized and asked China to take its Sinopharm Vaccine back
Philippines President Rodrigo Duterte, who has been criticized for introducing unproven vaccines, has asked Chinese Embassy to withdraw its 1,000 donated Sinopharm vaccines.
Duterte has stated that "I took a dose of Sinopharm under the Compassionate Use Clause (in which some people take unproven medicines if necessary) because their doctor advised them to take the vaccine."
According to the local media report, he appealed to the people not to do what I did, it is dangerous because no study has been done about it. It is possible that it is not good for the body, let me be the only person to take this vaccine, you should not take it."
China's Corona vaccine Sinopharm and Synovac may get approval from the World Health Organization this week.
As Sinopharm has not been approved so far, there are possibilities that it may have negative effects. Duterte said that it is sent back so that there is no further problem.
Both of these Chinese vaccines work on how to kill a virus virus, whereas Moderna and Fizer are mRNA vaccines, which work on the process of making viral proteins in the body.
At the moment, AstraZeneca and Synovac have received approval in the Philippines. However, it is not clear why Duterte did not get one of these two approved vaccines.
The Philippines is one of the countries most affected by the Corona virus in East Asia. There are 1 million corona infection cases in the country and so far 18,000 people have died due to infection.
DISCLAIMER: We make these content / news with the intention of sharing information, knowledge, and educating others in a motivational or inspirational form. We do not own some of the content we use, in some cases, may be provided directly/indirectly by other sources, however if any owners of the content would like us to remove that content / part of contect, we have no problem with that and will do so as-fast-as possible. if you have any concerns, please message us at info[at]bajar.in with "Content Removal < title >" in Subject.